The emergency use authorisation for Sputnik Light is unlikely to spark high demand for this single-shot vaccine in the short term, according to hospitals.
They are of the view that unless newer segments open up for vaccination, demand for Sputnik Light is unlikely to grow.
Dr Reddy’s Laboratories (DRL), the marketing partner of the Russian Direct Investment Fund (RDIF) for the Sputnik V and Sputnik Light vaccines, has sought government approval for the use of Sputnik Light as a booster shot or a precaution dose. It is also in discussions to supply Sputnik Light to public health programmes.
“The current